Can You Take HRT If You Are Overweight? Usually Yes — Here's What Your Weight Changes

Can you take HRT if you are overweight?

Yes, in most cases. Being overweight is not on the FDA estradiol label's list of reasons not to use the drug, and NICE sets no BMI limit. Instead, weight is treated as a risk factor to manage, mostly by choosing how the estrogen gets into your body.

Here's what each rulebook actually says. We read every one of these on October 26, 2026.

Two notes so you read this fairly. NICE is British guidance. A U.S. clinician doesn't have to follow it, but it's one of the clearest written statements on this exact question, and it's a fair thing to bring to an appointment. And "consider" means exactly that. It's not a promise of a prescription and not a rule that a patch is required.

What the FDA label does list as reasons not to use estradiol is short and specific: unexplained genital bleeding, breast cancer or a history of it, estrogen-dependent tumors, a current or past deep-vein clot or lung clot, a current or past stroke or heart attack, liver disease, a known clotting disorder, and allergy to the product. Weight is not on that list.

What do "overweight" and "obesity" mean here?

Body mass index (BMI) is your weight in kilograms divided by your height in meters squared. It's a rough screening number, not a verdict on your health. In adults, a BMI of 25 to 29.9 is usually called overweight, and 30 or higher is called obesity.

That difference matters because NICE's route advice is written for a BMI over 30. If your BMI is 27, weight is one small piece of your clot-risk picture. If it's 34, it's a bigger piece, and a patch, gel or spray is the usual first conversation. If it's exactly 30, don't treat the line like a cliff. Risk doesn't jump at one decimal point, and other factors can matter more.

Not sure of your BMI? Bring your height and weight to the visit. Your clinician will work it out.

Where do you fit? Weight, symptoms and the right next step

Your weight is only one piece of the decision. The table below sorts 10 common situations by what weight actually changes, what the evidence supports, and the most useful next step. Find the row closest to you.

How to read this table. Each row applies published guidance to a common situation. It's our editorial summary, not a diagnosis, a clot-risk score or a prescription. It hasn't been tested on patients. And a patch is never a pass that cancels out a serious history.

Why does being overweight change the blood-clot conversation?

A blood clot in a deep vein or the lungs is called venous thromboembolism, or VTE. Extra weight raises your starting risk of VTE on its own. Estrogen pills raise it further; in the main observational study of heavier women, estrogen through the skin did not show a statistically clear additional risk beyond that starting risk.

Here's the simple version of why. When you swallow estrogen, it travels to your liver first. That first pass nudges up the proteins your blood uses to clot. A patch, gel or spray goes in through the skin and mostly skips that trip.

What the clot study actually found

The best data on this exact question comes from the ESTHER study in France. Researchers compared 253 postmenopausal women aged 45 to 70 who had a first unexplained blood clot with 597 similar women who didn't. They looked at weight and how each woman took estrogen. (Canonico et al., Journal of Thrombosis and Haemostasis, 2006)

All numbers below compare each group with women whose BMI was under 25 and who were not taking estrogen. These are adjusted odds ratios, not personal risk percentages.

A much larger 2008 review in the BMJ pooled many studies and landed in the same place. Pills raised clot odds about 2.5 times; skin estrogen came in at about 1.2 times, a difference too small to be sure it was real. The review also found that pills combined with obesity pushed risk higher, while skin estrogen didn't seem to add risk in high-risk women. (Canonico et al., BMJ, 2008)

What "21 times" does and doesn't mean

These are odds compared with a healthy-weight woman on nothing. They are not your personal chance of getting a clot.

Clots are uncommon to begin with, but your starting risk changes with age and health history. Even a large relative number doesn't give you your actual chance of a clot. It is a real reason to ask about route.

Notice the wide range on the pill-plus-obesity number: 4.8 to 88.1. Few women fell into that exact group, so the estimate is fuzzy. The direction is consistent across studies, though: pills plus extra weight stack up.

This was one observational study. It shows a strong pattern, not proof. No large randomized trial has compared patches and pills head-to-head for clots. And "no added risk" isn't the same as "no risk." A woman with obesity on a patch still has the baseline risks that came with her weight and other health factors.

A worked example. Picture two women, both with a BMI of 32, neither with a past clot. One takes estradiol as a pill. The other uses a patch. In ESTHER, the pill-plus-obesity group had about 21 times the clot odds of a woman with BMI under 25 using no estrogen. The transdermal-plus-obesity group had about 5.4 times those reference odds—close to the 4.0 times found in women with obesity who were not using estrogen. The difference between 5.4 and 4.0 was not statistically clear. That's why many clinicians reach for a patch first. It isn't because weight rules her out.

The progestogen matters too

If you still have a uterus and take whole-body estrogen, you also need a progestogen. That's a progesterone-type drug that protects the lining of the uterus. The type may affect clot risk.

In the main ESTHER report, micronized progesterone, the body-identical kind sold as Prometrium and generics, was not linked to more clots (odds 0.7, range 0.3 to 1.9). One older group of synthetic progestins, called norpregnane derivatives, was linked to about 3.9 times the odds. (Canonico et al., Circulation, 2007) This is one study, but it's a good reason to ask, "Which progestogen, and why that one?"

Other things that raise clot risk besides weight

Bring these up even if you think they're minor. Each one changes the conversation:

• A personal history of a clot, or a parent or sibling who had one
• A known clotting disorder, such as Factor V Leiden
• Smoking
• Recent surgery, a cast, or long stretches of not moving, including long flights
• Lupus, which the estradiol label also names as a clot risk factor

NICE suggests women with a strong family history of clots or an inherited clotting disorder see a blood specialist before starting HRT. (NICE NG23) For the full picture on clots, read our guide to HRT and blood clots.

Your weight usually isn't the deciding factor. Your history is. The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

It's free, takes about 60 seconds and doesn't ask for your email. It asks five questions: what's bothering you most, what you've tried, your age, your state and your health history. If weight gain is the only thing you select, it points you toward weight-care options instead of HRT. It doesn't diagnose anything or decide whether hormones are right for you. A clinician does that. How Find My HRT Path works.

Is an HRT patch safer than a pill if you're overweight?

For blood clots, the evidence favors the patch. NICE says to consider skin estrogen rather than pills for women at higher clot risk, including a BMI over 30. But no route is risk-free, and a patch doesn't erase a past clot or a clotting disorder.

"Transdermal" just means through the skin. Patches, gels and sprays all deliver estradiol into your bloodstream through the skin. They're whole-body (systemic) treatments, the same as a pill, so they treat hot flashes and night sweats. They just take a different road in.

A few details that matter:

Gels and sprays are real options. FDA-approved estradiol gels and sprays exist. Some women prefer them to patches, especially if patches irritate their skin. See estradiol gel online and estradiol spray online.

A "bioidentical" cream isn't the same thing. FDA-approved products are finished medicines checked for dose and quality. Custom-compounded creams are not FDA-approved. The Menopause Society says compounded hormones "are not safer or more effective" than approved bioidentical ones. Don't assume a compounded cream gives the same clot profile, or protects your uterus. More in compounded vs FDA-approved HRT.

Fezolinetant has its own warning. Veozah carries a boxed warning, the FDA's strongest, for rare but serious liver injury. It needs liver blood tests before you start, monthly for the first three months, then at months six and nine (current FDA label on DailyMed). Read more about fezolinetant for hot flashes and other non-hormonal options.

Do you still need progesterone with a patch?

Yes, if you have a uterus. A patch changes how estrogen enters your body, not what estrogen does to the uterine lining. Without a progestogen, estrogen alone can thicken the lining and raise the risk of uterine cancer. The Menopause Society says women with a uterus taking whole-body estrogen must use a progestogen.

Options your clinician might discuss include micronized progesterone capsules, a combined estrogen-progestin patch, or, in some cases, a hormonal IUD. That last one is a clinical call; see can Mirena be used as the progesterone in HRT. If you've had a hysterectomy, you usually don't need a progestogen at all. More in do you need progesterone if you have a uterus.

Will a patch stick and work on a larger body?

We found no strong evidence that patches simply work worse at a higher weight. Most problems are practical. The FDA label says to apply the patch right after opening it, to clean, dry skin, and to press on it if it lifts. If it keeps peeling, ask about a different brand or a gel. Our guide on what to do when an estradiol patch won't stick has more.

If your symptoms aren't better, don't assume HRT "doesn't work for bigger bodies." NICE says to review any menopause treatment at about three months for whether it's helping and whether side effects are tolerable. That's the time to talk about dose or route. See how long until HRT starts working and signs your HRT dose may be too low.

For a deeper side-by-side, read estradiol patch vs pill and oral vs transdermal estrogen.

Which menopause symptom are you trying to treat?

Start with the symptom, not the scale. Whole-body estrogen treats hot flashes and night sweats. Low-dose vaginal estrogen treats dryness and painful sex, and HRT itself isn't a weight-loss treatment.

This sounds obvious, but it changes everything about the weight question.

Hot flashes and night sweats that wreck your sleep or your day. This is where whole-body HRT does its best work. The Menopause Society calls hormone therapy the most effective treatment for these symptoms. Here, the pill-or-patch question is the one that matters most at a higher weight.

Vaginal dryness, painful sex or repeat urinary symptoms. This group of symptoms is called genitourinary syndrome of menopause. It often responds to low-dose vaginal estrogen, which stays mostly local. The whole clot-and-weight discussion above may not even apply to you. Moisturizers and lubricants can help too. Read our vaginal estrogen guide.

Weight gain with no other menopause symptoms. Be honest with yourself here. HRT isn't designed to take weight off, and you'd be paying for a medicine that doesn't target your goal. A weight and metabolic review is the better first step. The HRT Index's Find My HRT Path tool routes weight-only answers to weight-care options for this reason.

Does being overweight change your breast or uterine cancer risk on HRT?

Being heavier raises your starting risk of both breast cancer after menopause and uterine cancer, whether or not you take HRT. For breast cancer, the added risk from HRT was smaller in heavier women in the largest analysis. For the uterus, the higher starting risk is exactly why the progestogen and prompt bleeding checks matter.

Breast cancer

The biggest analysis on this question pooled data on more than 100,000 women with breast cancer. It found HRT-linked risk was weaker in women with more body fat, especially for estrogen-only HRT, which had little effect in women with obesity. Estrogen plus a progestogen still carried more risk than estrogen alone. (Collaborative Group on Hormonal Factors in Breast Cancer, The Lancet, 2019)

In plain words: after menopause, body fat makes some estrogen on its own. So adding HRT changes breast tissue's exposure less than it would in a leaner woman. That doesn't make HRT risk-free. Your starting risk is already higher, and the National Cancer Institute lists obesity as a risk factor for breast cancer after menopause. (NCI)

FDA's 2026 label changes removed breast cancer from the boxed warning on several HRT products, but the risk is still described in the labels' warnings section. (FDA, February 2026) For more, read HRT and breast cancer risk and our 2026 label changes explainer.

Uterine (endometrial) cancer

Obesity is one of the strongest known risk factors for cancer of the uterine lining. The National Cancer Institute says women with overweight or obesity have two to four times the risk, and women with severe obesity about seven times the risk, of the most common type. (NCI obesity fact sheet, reviewed January 2025)

That's not a reason to avoid HRT. It's a reason to do it carefully:

• If you have a uterus, the progestogen is not optional with whole-body estrogen. When FDA revised HRT boxed warnings in 2026, it kept the uterine cancer boxed warning for whole-body estrogen-alone products.
• Report bleeding. NICE's updated 2026 advice says unexpected bleeding can be common in the first six months after starting systemic HRT, or the first three months after changing its dose or preparation. Mention it at the three-month review. Seek prompt medical assessment for bleeding beyond those windows, or earlier if bleeding is heavy or worrying. Bleeding that was unexplained before HRT still needs evaluation before starting.

Read more about HRT and endometrial cancer risk and bleeding after starting HRT.

What if you also have high blood pressure, diabetes or heart risks?

Weight often travels with high blood pressure, prediabetes or high cholesterol. NICE says these risk factors aren't a reason to refuse HRT as long as they're well managed, and that HRT doesn't raise the risk of type 2 diabetes. Pills, but not skin estrogen, are linked to a small rise in stroke risk.

What NICE tells clinicians to explain (NICE NG23):

• HRT doesn't increase heart disease risk when started before age 60.
• HRT doesn't change the risk of dying from heart disease.
• Estrogen pills, not skin estrogen, carry a small increase in stroke risk. The starting risk of stroke under 60 is very low.
• HRT, by pill or patch, isn't linked to developing type 2 diabetes.
• For women who already have type 2 diabetes, HRT can be considered after looking at their other conditions, with specialist advice if needed.

Uncontrolled blood pressure is different from managed blood pressure. If yours is high and untreated, getting it under control comes first. See HRT and high blood pressure and HRT and heart disease.

Age and timing can matter more than weight. The Menopause Society says the benefits are clearest when HRT is started under 60 or within 10 years of menopause. Starting later isn't an automatic no, but it calls for a more individual conversation. See our guide to online HRT for women over 60.

When should you see someone in person first?

See a clinician in person before starting HRT if you've had a blood clot, stroke or heart attack, have a clotting disorder, have bleeding no one has explained, have had breast or uterine cancer, or have liver disease. Weight on its own isn't on this list. A patch, an online form or a quiz can't clear these histories.

These come straight from the estradiol label's contraindications and The Menopause Society's list of women who generally shouldn't use hormone therapy:

• A past or current blood clot in a leg (DVT) or lung (PE)
• A past or current stroke or heart attack
• A known clotting disorder (protein C, protein S or antithrombin deficiency, or similar)
• Breast cancer, uterine cancer or another estrogen-dependent cancer
• Vaginal bleeding no one has explained
• Liver disease

Some of these may still leave options, such as non-hormonal medicines or, in some cases, low-dose vaginal estrogen. But that conversation belongs with a clinician who can examine you and see your records. Read who should not take HRT, HRT after a blood clot and HRT after a stroke.

To find a clinician with menopause training near you, The Menopause Society keeps a public practitioner directory.

Get emergency help now, not an appointment, for: new swelling, pain or warmth in one leg; sudden shortness of breath; chest pain that's worse when you breathe in; coughing up blood; a sudden severe headache; or trouble speaking or seeing. Call 911.

What if your doctor said you can't have HRT because of your weight?

Ask which specific risk led to that advice. Often the real concern is clot risk with estrogen pills, and a patch, gel or spray may change the answer. If there's something else in your history, you deserve to hear what it is.

Women describe this happening, and it stings. Sometimes the advice is sound. Sometimes it's a reflex based on old thinking about pills. You can find out which, calmly.

What to say (copy this)

"I understand my weight may change my risks. Can you tell me which risk makes HRT unsuitable for me? Does that apply to every form of estrogen, or mainly to pills? I've read that guidance in the U.K. says to consider a patch, gel or spray for women at higher clot risk, including a BMI over 30. Does that change anything for me? If not, could you explain the concern, and could you refer me to someone who treats menopause regularly?"

Why this works: it's respectful, it asks for a reason, and it gives the clinician something specific to respond to. You're not demanding a drug. You're asking for an explanation and a path.

If the answer is still no

Ask for three things:

1. The specific reason, written in your visit notes.
2. The alternatives they'd consider: a different route, local vaginal treatment, a non-hormonal medicine, or a referral.
3. A referral to a gynecologist or menopause-trained clinician if they don't prescribe HRT often.

A second opinion might confirm the first one. That's still a useful outcome. You'll know the reason is real.

Other places to start: our guides on how to ask your doctor for HRT, whether a primary care doctor can prescribe HRT, and finding a menopause specialist online.

If you're not sure which kind of clinician to try next, The HRT Index's Find My HRT Path tool asks about your history and state, then points you to an online option or tells you when in-person care makes more sense.

Will HRT make you gain weight — or help you lose it?

Neither, for most women. A Cochrane review of trials found HRT had no real effect on body weight or BMI. It isn't a weight-loss drug, though easing night sweats and broken sleep can make healthy habits easier.

The Cochrane review found no meaningful difference in BMI between women on HRT and women not taking it, whether estrogen alone or estrogen plus a progestogen. (Cochrane CD001018) The Menopause Society puts it simply: HT "is not associated with weight gain."

So why do some women feel heavier after starting? Early bloating and fluid are common, especially in the first weeks, and progesterone's label lists fluid retention. That's water, not fat. And menopause itself shifts fat toward the belly, whether or not you take hormones. Our page on whether HRT causes weight gain walks through how to tell the difference, and does HRT help with belly fat covers fat distribution.

Should you lose weight before asking for HRT? No guideline we reviewed makes weight loss a requirement. Losing weight lowers several of the risks on this page, and that's worth doing for its own sake. But untreated night sweats and broken sleep can make it harder. You can work on both at once.

Can you take HRT with a GLP-1 like Wegovy or Zepbound?

Many women do, and no rule says you can't, but plan it with your clinician. A 2026 Mayo Clinic study found women on HRT lost more weight on tirzepatide (Zepbound, Mounjaro) than women not on HRT. It can't prove HRT caused the difference.

What the study found: researchers looked back at 120 postmenopausal women with overweight or obesity who took tirzepatide for at least a year. Mayo Clinic, whose researchers led the study, says the women also using HRT lost about 35% more weight on average than those not on HRT—a relative comparison, not 35 percentage points of body weight. (Mayo Clinic's report of the study; original journal study, Castaneda et al., 2026) The authors say plainly that this wasn't a randomized trial, so women on HRT may simply have had other healthy habits.

The pill question. GLP-1 medicines slow how fast your stomach empties. Tirzepatide's FDA label says this can change how swallowed medicines are absorbed, and it tells women on birth control pills to switch to a non-pill method or add a barrier method for four weeks after starting and after each dose increase. Eli Lilly says its use with oral HRT hasn't been studied. (Lilly Medical Information)

You'll see posts online saying GLP-1s "block" progesterone. We didn't find proof of that. The honest version is that nobody has tested it well. If you take swallowed estrogen or progesterone, ask your clinician how they'll make sure your uterus stays protected. Skin estrogen doesn't go through the gut, which is one more reason some clinicians favor it.

Our guide can you take HRT and a GLP-1 together covers this drug by drug. If you're choosing a clinic that handles both, see online menopause clinics that prescribe GLP-1s.

A note on Gala: Gala's HRT pages say that if weight is a main concern, a Gala clinician can discuss whether a GLP-1 makes sense alongside or instead of HRT. Gala's weight program is a separate program with its own pricing. Nothing on this page about Gala's HRT price, medications or reviews applies to it.

How much does the patch route cost compared with pills?

It depends where you get it. At Alloy, the patch costs $100 a month versus $39.99 for the pill, so a patch can mean paying more. Gala advertises one flat $69 a month that it says doesn't rise with your dose, so confirm the patch is included before you pay.

This matters for heavier women in particular. If you're more likely to be steered toward a patch, the "patch premium" at some services lands on you.

What each route costs (cash-pay examples)

These are examples built from published prices, not quotes. Promo codes and first-month discounts are left out on purpose. A 3-month or 12-month membership requires paying for that period; the monthly equivalent is not its checkout charge. "Plus medicine" or any unpriced required treatment means the total is incomplete, not $0. Gala's totals are conditional examples because its exact HRT billing interval and medication bundle are unconfirmed. The price on your own checkout screen is the one that counts.

The patch premium, worked out

Say a clinician recommends a patch for you, and you're paying cash.

• At Alloy: the patch is $100 per month of supply. The pill starts at $39.99 per month of supply on Alloy's current product page. That's $60.01 more per month, or $720.12 more per year, for the same goal of treating hot flashes. The first patch charge is $349 for three months and the initial consult, excluding any extra progesterone you need.
• At Gala: the advertised HRT price is $69 a month with no dose-based price rise, but we couldn't confirm that a prescribed patch costs the same or that progesterone is included. If both are included at $69 per calendar month, 12 charges would be $828—$421 less than Alloy's $1,249 patch-only first-year example, before adding progesterone at Alloy. If Gala bills 28-day cycles instead, 14 charges would be $966, making that conditional gap $283. Any additional required Gala fees would change both comparisons.

That "if" is the whole question. Gala's HRT landing page says your exact plan and price are shown before you pay. Look for the patch and progesterone on that screen before you enter a card.

Why "monthly" doesn't always mean 12 charges

Some services bill every 28 days, not every calendar month. That adds up.

Hypothetical example at $69: billed on the 1st of each month starting November 1, you'd see three charges in 90 days ($207). Billed every 28 days starting November 1, you'd be charged on November 1, November 29, December 27 and January 24 — four charges ($276) in the same 90 days, and 14 charges ($966) in a year.

Ask any service: "Do you bill every month or every 28 days?"

A cost worksheet you can copy

MY HRT COST CHECK (keep this private)

Service: ______________________
Charged at first order:      $______
Then charged:                $______ every ______ (month / 28 days / 3 months)
Patch included?              yes / no / unknown
Progesterone included?       yes / no / unknown
Labs if ordered:             included / $______ / unknown
Shipping:                    included / $______
Last safe day to cancel:     ______________________

FIRST 90 DAYS = every charge in 90 days + every required extra
If anything says "unknown," my total is INCOMPLETE. Don't write $0.

For more price math across providers, see HRT cost in 2026, the cheapest estradiol patch without insurance, and does insurance cover the estradiol patch.

If you're paying cash and a patch is likely for you, Gala's flat advertised price could be an advantage here — but only if the patch, needed progesterone and required services are truly included at checkout. Check the plan screen and renewal interval before you pay.

Where can you get HRT online if you're overweight?

Any reputable online menopause service should review your full history, not turn you away for weight alone. For cash-pay care where a clinician can consider a pill or patch, Gala is our featured option with a $69 advertised starting point. The price for your exact medication still needs confirmation. If you need insurance, Midi or Evernow can fit better; if you want a posted patch price up front, Alloy publishes one, though you still need to confirm its exact product.

Why Gala fits many women reading this page

Here's what Gala's own pages say, read October 26, 2026. These are Gala's statements, not something we tested.

• The medicines a heavier woman is likely to discuss. Gala lists four treatment groups: estradiol pills or patches; micronized progesterone to protect the uterine lining; vaginal estradiol cream or tablets for dryness, painful sex and recurring UTIs; and non-hormonal medicines including fezolinetant, for women who can't or don't want to use hormones. A clinician has to approve any of them.
• One advertised price that doesn't rise with your dose. Gala's HRT landing page advertises $69 a month, "flat," covering the online visit, prescription and shipping, with no membership fee and "no price rise when your dose changes." If your actual prescription includes a patch and any needed progesterone at that price, it may remove the patch premium described above; the exact bundle and billing interval still need confirmation.
• A history review, not a weight gate. Gala says a U.S.-licensed clinician reads your full assessment before prescribing, and that it doesn't prescribe "when the risk doesn't make sense." Some states require a short video visit first. We found no BMI limit on its HRT pages.
• Ongoing support. Gala says provider messaging, symptom check-ins and dose adjustments continue as long as you're treated.
• A non-hormonal backup in the same place. If hormones turn out not to fit your history, the same service lists fezolinetant.
• Payment. Cash-pay only. Gala accepts FSA and HSA cards.

One woman, quoted on Gala's own site, described the experience this way: "Gala's provider walked me through the options." (Allison, 51, as published on Gala's hormone-health page. Gala chose and posted this; it isn't independently verified and isn't evidence of typical results.)

Where Gala isn't the right fit

Be clear-eyed about these before you click:

• It doesn't bill insurance. If your plan would cover a visit and a generic patch, that may cost you less.
• It doesn't name the exact patch or publish a state list or HRT age range. Gala's pages say "FDA-approved bioidentical forms," but one of its alternate landing pages carries a compounded-medication notice, as we documented in our Gala HRT review. Ask which product you'd get.
• Cancelling has caused friction for some. One reviewer on the Better Business Bureau site wrote that it "was very easy to start my subscription for HRT," but said cancelling was hard and she had to email without a clear timeline (September 1, 2026, as recorded in our Gala review; one person's account). Gala's general policy, as documented in our review, specifies a 72-hour cutoff before your billing date; we could not confirm that it governs this exact HRT order. Screenshot your checkout, ask which cancellation terms apply, note your billing date and cancel in writing early if you need to.
• It's not for red-flag histories. A past clot, stroke, heart attack, hormone-sensitive cancer or unexplained bleeding belongs with an in-person clinician first.

How the main routes compare for a woman at a higher weight

Our read: Gala is our featured cash-pay option for this situation. That's a commercial placement we disclose, not a finding that it's medically safer for heavier women than anyone else. If insurance, a named product or a complex history changes the match, the better fit is in the other columns.

No red flags, paying cash, and you'd like a clinician to consider a patch? Gala lists that route. Check whether the patch and any needed progesterone are in the advertised $69, and confirm the billing interval, before you pay.

What should you bring to your appointment?

Bring your height and weight, your blood pressure if you know it, any clot or cancer history, whether you have a uterus, and every medicine you take, including any GLP-1. Then ask the questions below.

Print this, screenshot it, or copy it into your notes.

MY MENOPAUSE VISIT CARD (keep this private)

ABOUT ME
[ ] My top two symptoms, and how often:  ____________________
[ ] My age: ____   Last period: ____________
[ ] I have a uterus:  yes / no
[ ] Height: ______   Weight: ______   (or BMI: ______)
[ ] Blood pressure, if known: ______
[ ] Past blood clot, stroke or heart attack:  yes / no
[ ] Parent or sibling with a blood clot:  yes / no
[ ] Breast or uterine cancer history:  yes / no
[ ] Bleeding I can't explain:  yes / no
[ ] I smoke:  yes / no
[ ] Medicines I take (include GLP-1s, blood thinners, supplements):
    ______________________________________________
[ ] What I've already tried, and what helped: ______________

MY QUESTIONS
1. Is my weight a concern for you? Which risk exactly?
2. Would a patch, gel or spray suit me better than a pill?
3. Which progestogen will protect my uterus, and why that one?
4. What's the exact product name? Is it FDA-approved or compounded?
5. I'm on (or thinking about) a GLP-1. Does that change anything?
6. When will we check whether it's working? (Three months?)
7. What bleeding or symptoms should make me call you?

IF ONLINE
- Is the patch included in my price? Is progesterone?
- What's my billing date? Monthly or every 28 days?
- How do I cancel, and how much notice do you need?

WHAT THE CLINICIAN SAID
Reason / plan: _______________________________________
Referral or next step: ________________________________

This card doesn't diagnose anything, score your risk or choose a treatment. It helps your clinician see the full picture quickly, so the visit isn't all about one number.

How we researched this page

We read the FDA estradiol label, NICE and Menopause Society guidance, and the main studies on weight, route and risk, then checked Gala's, Alloy's and Evernow's public pages on October 26, 2026. We didn't examine anyone or test any service; this is documentation review.

We use The HRT Index Verification Standard, which asks five questions of every care option, in this order:

These five pillars group the more detailed criteria in our full methodology. We don't give providers scores on this page.

How we label claims:

• Medical and regulatory facts come from the FDA, NICE, The Menopause Society, the National Cancer Institute and peer-reviewed studies, linked beside each claim.
• Provider facts come from each company's own pages, with the date we read them.
• Our judgment — like which situations suit Gala — is labeled as ours.

This page is editorial research and hasn't been reviewed by a clinician. See our medical review policy. Gala is a disclosed affiliate partner; Alloy, Evernow and Midi are linked without commission on this page. Affiliate disclosure.

Frequently asked questions

Is there a weight limit for HRT?

There's no official BMI cutoff in the FDA estradiol label or NICE guidance. Individual clinicians or clinics may use their own rules, so ask what's behind any limit you're given.

Can someone with a BMI of 35 or 40 take HRT?

A BMI number alone doesn't answer it. A higher BMI is a stronger reason to look at clot risk and consider a patch, gel or spray instead of a pill, but a clinician has to weigh your whole history.

Is an HRT patch safer than a pill if I'm overweight?

For blood clots, studies favor the patch, and NICE says to consider skin estrogen above a BMI of 30. A patch lowers the added clot concern; it doesn't erase a past clot or a clotting disorder.

Can my doctor refuse HRT because of my weight?

A clinician can decline to prescribe. Ask which specific risk worries them and whether a patch, gel or spray changes it, and ask for a referral or second opinion if you're not satisfied.

Will HRT make me gain weight?

Trials show HRT doesn't change body weight or BMI for most women. Early bloating is usually fluid and often settles.

Will HRT help me lose weight?

No. HRT isn't a weight-loss treatment, though better sleep and fewer night sweats can make healthy routines easier.

Can I take HRT and Wegovy or Zepbound together?

Many women do, and nothing rules it out, but plan it with your clinician. GLP-1s slow stomach emptying, and their effect on swallowed HRT hasn't been well studied.

Do I need progesterone if I use a patch?

If you have a uterus and use whole-body estrogen, yes, you need a progestogen to protect the uterine lining, whatever your weight. If you've had a hysterectomy, you usually don't.

Is vaginal estrogen the same as an HRT patch?

No. Low-dose vaginal estrogen mostly stays local and treats dryness and painful sex; very little reaches your blood. A patch is whole-body treatment for hot flashes and night sweats.

Does HRT work as well if I'm heavier?

HRT is still the most effective treatment for hot flashes and night sweats, and we found no strong evidence that it simply doesn't work at a higher weight. If you're not better after about three months, review the dose or route with your clinician.

Do I need blood tests to start HRT?

Often not. Menopause is usually diagnosed from symptoms, age and periods. Tests may be needed for another condition, and fezolinetant requires liver tests under its FDA label.

If I still have periods, is HRT birth control?

No. Menopause HRT isn't a contraceptive. If pregnancy is still possible, talk with your clinician about contraception too.

The bottom line

Your weight usually changes how you take HRT, not whether you can. Ask about a patch, gel or spray. Make sure your uterus is protected if you have one. Check the red flags. And if you're paying cash, price the patch route before you pay.

If any of the red flags apply, start with an in-person clinician. If none do and you know you want a clinician to look at your symptoms, a cash-pay online service like Gala can review your history and consider a patch.

Still not sure which kind of care fits your history, age and state? The HRT Index's Find My HRT Path tool takes about a minute, is free and doesn't ask for your email. It'll show you a featured option, or tell you when online care isn't the right place to start.

Sources

Guidance and labels (read October 26, 2026)

• NICE, Menopause: identification and management (NG23), recommendations
• Estradiol Transdermal System, current product prescribing information on DailyMed: contraindications and warnings
• The Menopause Society, Hormone Therapy (page modified July 29, 2026)
• FDA, Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms (February 13, 2026)
• FDA, Labeling changes to menopausal hormone therapy products (February 12, 2026)
• National Cancer Institute, Obesity and Cancer fact sheet (reviewed January 28, 2025)
• Eli Lilly Medical Information: Zepbound with oral contraceptives or HRT
• Zepbound prescribing information on DailyMed, section 7.2
• Veozah (fezolinetant), current prescribing information and liver-test schedule on DailyMed

Studies

• Canonico M, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study (full text and Table 3). J Thromb Haemost. 2006;4(6):1259–65.
• Canonico M, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation. 2007;115:840–5.
• Canonico M, et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ. 2008;336:1227.
• Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk (primary PubMed abstract). The Lancet. 2019;394:1159–68.
• Cochrane review CD001018: Hormone replacement therapy has no effect on body weight
• Castaneda R, et al. The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity. Lancet Obstet Gynaecol Womens Health. 2026;2:e118. First-party Mayo Clinic study report.

Providers (read October 26, 2026 unless noted)

• Gala — Hormone Health
• Gala — Estradiol pill or patch
• Gala — Non-hormonal options
• Gala — HRT landing page, $69 offer
• Alloy — Estradiol patch
• Alloy — Estradiol pill
• Alloy — Progesterone
• Evernow — Menopause care
• Evernow — Membership and insurance FAQ (actual prepaid term prices)
• Midi Health — Pricing and insurance (checked October 26, 2026)
• The HRT Index — Gala Health HRT review (Gala general refund policy and BBB review documented in that article October 10–15, 2026; original BBB and HRT-specific cancellation terms not reverified).

The HRT Index is an independent editorial publication. We are not a healthcare provider, pharmacy or telehealth service. Nothing here is medical advice, a diagnosis or a treatment plan. For decisions about starting, stopping or changing hormone therapy, talk with a licensed clinician who knows your history. In an emergency, call 911.